SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Advanced Enzyme Technologies L

BSE: 540025 29 Jun 2025
Healthcare
₹ 339
Advanced Enzyme Technologies Limited specializes in Biotechnology within the Healthcare sector.

Advanced Enzyme Technologies L - Share Price & Details

Market Cap
₹3,689
High /Low
571.0 / 258.0
Stock P/E
28.1
Book Value
₹127.0
Dividend Yield
1.58
ROCE
13.0
ROE
₹9.55
Face Value
2.0
PEG Ratio
100.0
EVEBITDA
₹15.9
Debt
39.4
CMP / FCF
36.3
Debt to equity
₹0.03
NP Ann
134
High price all time
571.0
Piotroski score
₹5.0
Graham Number
183.0
No. Eq. Shares
11.2
Net CF
₹-19.2
Net profit
134
Price to book value
2.6
Interest Coverage
₹53.6
Low price all time
91.0
Industry PE
28.1
Reserves
₹1,398
Free Cash Flow
₹108

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Advanced Enzyme Technologies L917.36110.54872.060.993,68928.1
Artemis Medicare Services Limi2470.34232.052348.011.47352842.9
GUFIC BIOSCIENCES LTD.NANANANA350150.3

Peer Comparison Chart


About Advanced Enzyme Technologies L

Advanced Enzyme Technologies Limited, with Security Code 540025, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Advanced Enzyme Technologies Shows Mixed Technical Trends Amid Market Evaluation Changes

(15 Jun 2025)
Advanced Enzyme Technologies, a small-cap in the Pharmaceuticals & Biotechnology sector, has experienced a recent stock price adjustment.
Read more →

Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Due To Pay A Dividend Of ₹1.20

(12 Jun 2025)
The board of Advanced Enzyme Technologies Limited ( NSE:ADVENZYMES ) has announced that it will pay a dividend of ₹1.20...
Read more →

Had a 30% plus growth last year, see that traction continuing: Piyush Rathi, Advanced Enzymes

(16 May 2025)
Piyush Rathi, Chief Business Officer, Advanced Enzymes, talks about FY 17 projections, revenue growth and new inventions.
Read more →

Advanced Enzyme Technologies Reports Decline in Profitability and Operational Efficiency in March 2025 Results

(14 May 2025)
Advanced Enzyme Technologies has announced its financial results for the quarter ending March 2025, highlighting operational challenges.
Read more →

Advanced Enzyme Technologies consolidated net profit declines 6.46% in the March 2025 quarter

(14 May 2025)
Sales rise 5.93% to Rs 167.18 crore. Net profit of Advanced Enzyme Technologies declined 6.46% to Rs 26.48 crore in the quarter ended March...
Read more →

Advanced Enzyme Standalone March 2025 Net Sales at Rs 87.21 crore, down 5.62% Y-o-Y

(14 May 2025)
Net Sales at Rs 87.21 crore in March 2025 down 5.62% from Rs. 92.40 crore in March 2024. Story continues below Advertisement.
Read more →